TD Cowen analyst inquired about growth contributions regarding Myriad Genetics.
3 reports, 3 independent
Updated Sep 9
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen analyst inquired about growth contributions regarding Myriad Genetics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Myriad Genetics
American biotechnology company
Coverage
Newest first; wire copies grouped- tickerreport.com
- StockStoryMyriad Genetics’s Q2 Earnings Call: Our Top 5 Analyst Questions Myriad Genetics reported flat year-over-year sales in Q2, but the market responded positively due to results that surpassed Wall Street
- Insider MonkeyTD Cowen Maintained a Hold Rating on Myriad Genetics (MYGN) Myriad Genetics, Inc. (NASDAQ:MYGN) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Daniel Brennan from TD Cowen maint